Colanar partners with 503A and 503B facilities to produce drugs in sterile environments. Our automated solutions help compounders across the United States meet rising product demand safely and efficiently.

Colanar is a proud 2025 Corporate Patron of the Alliance for Pharmacy Compounding (APC).